CareEvolve and ZoomMed USA Will Offer Integrated e-Prescribing to 30,000 Physicians

CareEvolve and ZoomMed USA Will Offer Integrated e-Prescribing to 30,000 Physicians

<0> CareEvolve.comLinda Newman, 888-322-5222 ext. 7341Director of MarketingorZoomMedYves Marmet, 450-678-5457 ext. 228President and CEO </0>, Inc., a wholly-owned subsidiary of BioReference Laboratories, Inc (NASDAQ: BRLI), and ZoomMed USA have announced an agreement which will allow CareEvolve’s 30,000 provider users to access e-prescribing using ZoomMed’s ZRx Prescriber service.

CareEvolve provides physician portals to clinical laboratories for use by their provider clients for Computerized Physician Order Entry (CPOE), electronic results storage, review and analytics. ZoomMed’s ZRx service has been seamlessly integrated into the CareEvolve physician portal.

According to The Centers for Medicare and Medicaid Services (CMS) website: “A prescriber's ability to electronically send an accurate, error-free and understandable prescription directly to a pharmacy from the point-of-care is an important element in improving the quality of patient care.”

ZoomMed’s ZRx Prescriber has been certified by SureScripts for Prescription Routing, Prescription Benefits and Medication History. It meets government requirements for CMS’s eRx Incentive Program. Electronic prescribing improves patient safety by eliminating errors from handwriting illegibility, wrong dosing, missed drug interactions or drug/allergy reactions. It also saves providers' time by automating the transfer of new prescriptions to pharmacies and approving renewal requests.

CareEvolve is a wholly-owned subsidiary of BioReference Laboratories, Inc, and has been connecting laboratories to physicians since 1999. CareEvolve’s Electronic Medical Record (EMR) connectivity solutions deliver results to and accept orders from virtually every electronic medical record on the market today. CareEvolve also provides an Internet-based Computerized Physician Order Entry (CPOE) and results reporting solution for clinical laboratory, pathology and radiology outreach businesses. Patient Portal and e-Prescribing modules have recently been introduced. CareEvolve's browser independent, cloud based software is compatible with smart phones and tablets, giving providers remote access to clinical information. The CareEvolve solution is used by over 30,000 physicians every day.

BRLI is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. We believe that we are the fourth largest full-service laboratory in the United States and the largest independent regional laboratory in the Northeastern market. BRLI offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. BRLI primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, women’s health and correctional health care.

ZoomMed is a leader in e-prescribing. Their ZRx Prescriber delivers e-prescribing simplicity for the provider and encourages compliance and persistence in patients. It is a SureScripts certified application that can be integrated with any Electronic Medical Record (EMR) application. The Web application is compatible with wireless devices such as iPhone™, iPad™, and Google Android™ based platforms. It also operates on Internet connected workstations and laptop computers using Windows and Mac operating systems. More than 30 million new prescriptions and renewals are processed each year by ZoomMed products.

In addition to ZRx Prescriber, ZoomMed also offers a Clinical Information Exchange platform between physicians and various other stakeholders of the health sector, such as pharmacists, specialists, pharmaceutical corporations, specialized clinics, health payers and others. ZoomMed also offers Web based pharmacy management software.

ZoomMed USA is a wholly owned subsidiary of ZoomMed Inc. Founded in 2005, ZoomMed Inc., with corporate offices in Quebec and Ontario, Canada, (symbol: ZMD) is a publicly traded company listed on the Canadian TSX Venture Exchange.